6 May 2009
Relief possible for sufferers of inflammatory diseases
Drug-buying agency Pharmac announced yesterday it will carry out public consultation on a proposal to fund the drug adalimumab.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
